Search results
Norman Edward "Ned" Sharpless (born September 20, 1966) is the previous Director of the National Cancer Institute (NCI). Before that, Sharpless was Professor of Medicine and Genetics Chair, Director of University of North Carolina UNC Lineberger Comprehensive Cancer Center , Molecular Therapeutics, Wellcome Distinguished Professorship in Cancer ...
Apr 4, 2022 · Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Dr. Sharpless will continue as NCI director through April 29, 2022, to allow for a thorough transition.
Apr 4, 2022 · Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Dr. Sharpless will continue as NCI director through April 29, 2022, to allow for a thorough transition.
Apr 4, 2022 · Norman “Ned” Sharpless, director of the $6.9 billion National Cancer Institute (NCI) since late 2017, announced today that he will step down at the end of this month after nearly 5 years on the job. Sharpless’s announcement stunned many in the cancer research community.
Norman E. Sharpless, M.D. (he/him) Director, National Cancer Institute. r. E. “Ned” Sharpless was officially sworn in as the as of of the Lineberger appointment, of North Comprehensive. Institute (NCI) on Dr. Sharpless Center at the University he held since 2014. Sharpless his undergraduate a Morehead mathematics. Medicine, graduating UNC ...
Nov 4, 2019 · Norman E. “Ned” Sharpless, M.D., served as Acting Commissioner of Food and Drugs from April 5, 2019 to November 1, 2019. Previously, he was appointed as the 15th director of the National ...
Apr 4, 2022 · Norman E. Sharpless, MD. Dr. Sharpless was sworn in as the 15th Director of NCI on October 17, 2017. He also served as Acting Commissioner for Food and Drugs at the U.S. Food and Drug Administration (FDA) for 7 months in 2019 before returning to the NCI directorship. “During my time in the federal government, I have been inspired by the ways ...
